The Human Health Operations Executive Director of HIPRA, Jordi Ruano, attended the PDA – Parenteral Drug Association BioManufacturing Conference held in Rotterdam, where he had the opportunity to present the European project SPEEDCELL, led by HIPRA and funded by the EU4Health program.

During his presentation, Ruano not only introduced the core of the project but also emphasized its transformative ambition: to develop vaccines in just 100 days. This goal, which is aligned with the European Union’s priorities to enhance preparedness and response to health emergencies, represents a paradigm shift in the way future pandemics are addressed.

Ruano also shared concrete examples of how our R&D, Production, and Quality teams are working together to make this vision a reality.

His presentation sparked great interest among the PDA community, which highlighted the importance of projects like SPEEDCELL in strengthening Europe’s strategic autonomy and accelerating vaccine access in crisis situations.